4//SEC Filing
Carter Todd Alfred 4
Accession 0001104659-25-012200
CIK 0001640266other
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 4:22 PM ET
Size
5.6 KB
Accession
0001104659-25-012200
Insider Transaction Report
Form 4
Carter Todd Alfred
Chief Scientific Officer
Transactions
- Sale
Common Stock
2025-02-11$4.45/sh−5,413$24,088→ 81,023 total
Footnotes (2)
- [F1]Represents shares of common stock sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on February 9, 2025. The sales do not represent a discretionary trade by the reporting person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.13 to $5.00, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
Documents
Issuer
Voyager Therapeutics, Inc.
CIK 0001640266
Entity typeother
Related Parties
1- filerCIK 0001944011
Filing Metadata
- Form type
- 4
- Filed
- Feb 11, 7:00 PM ET
- Accepted
- Feb 12, 4:22 PM ET
- Size
- 5.6 KB